Russian COVID-19 vaccine is 92% effective, interim data suggest

Phase 3 clinical trial results indicate that Russia’s Sputnik V vaccine was 92% effective against COVID-19, according to a press release from the Russian Direct Investment Fund, or RDIF.“The use of the vaccine and the results of clinical trials demonstrate that it is an efficient solution to stop the spread of coronavirus infection, preventive health care tool, and this is the most successful path to defeat the pandemic,” Mikhail Murashko, Minister of Health of the Russian Federation, said in the release.Russian President Vladimir Putin announced his country’s approvalRead More

Share on facebook
Share on twitter
Share on linkedin